Proteasome functional insufficiency in cardiac pathogenesis

Xuejun Wang, Jie Li, Hanqiao Zheng, Huabo Su, Saul R. Powell

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The ubiquitin-proteasome system (UPS) is responsible for the degradation of most cellular proteins. Alterations in cardiac UPS, including changes in the degradation of regulatory proteins and proteasome functional insufficiency, are observed in many forms of heart disease and have been shown to play an important role in cardiac pathogenesis. In the past several years, remarkable progress in understanding the mechanisms that regulate UPS-mediated protein degradation has been achieved. A transgenic mouse model of benign enhancement of cardiac proteasome proteolytic function has been created. This has led to the first demonstration of the necessity of proteasome functional insufficiency in the genesis of important pathological processes. Cardiomyocyte-restricted enhancement of proteasome proteolytic function by overexpression of proteasome activator 28α protects against cardiac proteinopathy and myocardial ischemia-reperfusion injury. Additionally, exciting advances have recently been achieved in the search for a pharmacological agent to activate the proteasome. These breakthroughs are expected to serve as an impetus to further investigation into the involvement of UPS dysfunction in molecular pathogenesis and to the development of new therapeutic strategies for combating heart disease. Aninterplay between the UPS and macroautophagy is increasingly suggested in noncardiac systems but is not well understood in the cardiac system. Further investigations into the interplay are expected to provide a more comprehensive picture of cardiac protein quality control and degradation.

Original languageEnglish (US)
Pages (from-to)2207-2219
Number of pages13
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume301
Issue number6
DOIs
StatePublished - Dec 1 2011
Externally publishedYes

Fingerprint

Proteasome Endopeptidase Complex
Ubiquitin
Proteolysis
Heart Diseases
Myocardial Reperfusion Injury
Autophagy
Pathologic Processes
Reperfusion Injury
Cardiac Myocytes
Quality Control
Transgenic Mice
Myocardial Ischemia
Proteins
Pharmacology

Keywords

  • Congestive heart failure
  • Ischemia-reperfusion injury
  • Proteasome activator
  • Proteinopathy
  • Ubiquitin ligase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Proteasome functional insufficiency in cardiac pathogenesis. / Wang, Xuejun; Li, Jie; Zheng, Hanqiao; Su, Huabo; Powell, Saul R.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 301, No. 6, 01.12.2011, p. 2207-2219.

Research output: Contribution to journalArticle

@article{f108e8eb5c2243a3a7bae44ff6b8975d,
title = "Proteasome functional insufficiency in cardiac pathogenesis",
abstract = "The ubiquitin-proteasome system (UPS) is responsible for the degradation of most cellular proteins. Alterations in cardiac UPS, including changes in the degradation of regulatory proteins and proteasome functional insufficiency, are observed in many forms of heart disease and have been shown to play an important role in cardiac pathogenesis. In the past several years, remarkable progress in understanding the mechanisms that regulate UPS-mediated protein degradation has been achieved. A transgenic mouse model of benign enhancement of cardiac proteasome proteolytic function has been created. This has led to the first demonstration of the necessity of proteasome functional insufficiency in the genesis of important pathological processes. Cardiomyocyte-restricted enhancement of proteasome proteolytic function by overexpression of proteasome activator 28α protects against cardiac proteinopathy and myocardial ischemia-reperfusion injury. Additionally, exciting advances have recently been achieved in the search for a pharmacological agent to activate the proteasome. These breakthroughs are expected to serve as an impetus to further investigation into the involvement of UPS dysfunction in molecular pathogenesis and to the development of new therapeutic strategies for combating heart disease. Aninterplay between the UPS and macroautophagy is increasingly suggested in noncardiac systems but is not well understood in the cardiac system. Further investigations into the interplay are expected to provide a more comprehensive picture of cardiac protein quality control and degradation.",
keywords = "Congestive heart failure, Ischemia-reperfusion injury, Proteasome activator, Proteinopathy, Ubiquitin ligase",
author = "Xuejun Wang and Jie Li and Hanqiao Zheng and Huabo Su and Powell, {Saul R.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1152/ajpheart.00714.2011",
language = "English (US)",
volume = "301",
pages = "2207--2219",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Proteasome functional insufficiency in cardiac pathogenesis

AU - Wang, Xuejun

AU - Li, Jie

AU - Zheng, Hanqiao

AU - Su, Huabo

AU - Powell, Saul R.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The ubiquitin-proteasome system (UPS) is responsible for the degradation of most cellular proteins. Alterations in cardiac UPS, including changes in the degradation of regulatory proteins and proteasome functional insufficiency, are observed in many forms of heart disease and have been shown to play an important role in cardiac pathogenesis. In the past several years, remarkable progress in understanding the mechanisms that regulate UPS-mediated protein degradation has been achieved. A transgenic mouse model of benign enhancement of cardiac proteasome proteolytic function has been created. This has led to the first demonstration of the necessity of proteasome functional insufficiency in the genesis of important pathological processes. Cardiomyocyte-restricted enhancement of proteasome proteolytic function by overexpression of proteasome activator 28α protects against cardiac proteinopathy and myocardial ischemia-reperfusion injury. Additionally, exciting advances have recently been achieved in the search for a pharmacological agent to activate the proteasome. These breakthroughs are expected to serve as an impetus to further investigation into the involvement of UPS dysfunction in molecular pathogenesis and to the development of new therapeutic strategies for combating heart disease. Aninterplay between the UPS and macroautophagy is increasingly suggested in noncardiac systems but is not well understood in the cardiac system. Further investigations into the interplay are expected to provide a more comprehensive picture of cardiac protein quality control and degradation.

AB - The ubiquitin-proteasome system (UPS) is responsible for the degradation of most cellular proteins. Alterations in cardiac UPS, including changes in the degradation of regulatory proteins and proteasome functional insufficiency, are observed in many forms of heart disease and have been shown to play an important role in cardiac pathogenesis. In the past several years, remarkable progress in understanding the mechanisms that regulate UPS-mediated protein degradation has been achieved. A transgenic mouse model of benign enhancement of cardiac proteasome proteolytic function has been created. This has led to the first demonstration of the necessity of proteasome functional insufficiency in the genesis of important pathological processes. Cardiomyocyte-restricted enhancement of proteasome proteolytic function by overexpression of proteasome activator 28α protects against cardiac proteinopathy and myocardial ischemia-reperfusion injury. Additionally, exciting advances have recently been achieved in the search for a pharmacological agent to activate the proteasome. These breakthroughs are expected to serve as an impetus to further investigation into the involvement of UPS dysfunction in molecular pathogenesis and to the development of new therapeutic strategies for combating heart disease. Aninterplay between the UPS and macroautophagy is increasingly suggested in noncardiac systems but is not well understood in the cardiac system. Further investigations into the interplay are expected to provide a more comprehensive picture of cardiac protein quality control and degradation.

KW - Congestive heart failure

KW - Ischemia-reperfusion injury

KW - Proteasome activator

KW - Proteinopathy

KW - Ubiquitin ligase

UR - http://www.scopus.com/inward/record.url?scp=82855176954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82855176954&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00714.2011

DO - 10.1152/ajpheart.00714.2011

M3 - Article

C2 - 21949118

AN - SCOPUS:82855176954

VL - 301

SP - 2207

EP - 2219

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6

ER -